Results 51 to 60 of about 40,945 (273)
Journal of Neuroinflammation, 2011 Background 3,4-Methylenedioxymethamphetamine (MDMA) produces a neuroinflammatory reaction in rat brain characterized by an increase in interleukin-1 beta (IL-1β) and microglial activation.
O'Shea Esther +5 more
doaj +1 more source
ERP evidence suggests executive dysfunction in ecstasy polydrug users [PDF]
, 2013 Background: Deficits in executive functions such as access to semantic/long-term memory have been shown in ecstasy users in previous research. Equally, there have been many reports of equivocal findings in this area.
A Gamma +53 more
core +1 more source
Scientific Reports, 2021 3,4-Methylenedioxymethamphetamine (MDMA) is currently being evaluated by the Food and Drug Administration (FDA) for the treatment of post-traumatic stress disorder (PTSD).
Isaac V. Cohen +3 more
semanticscholar +1 more source
A review on the mitochondrial toxicity of “ecstasy” (3,4-methylenedioxymethamphetamine, MDMA)
Current Research in Toxicology, 2022 3,4-Methylenedioxymethamphetamine (MDMA or “ecstasy”) is a drug of abuse used by millions worldwide. MDMA human abuse and dependence is well described, but addictive properties are not always consistent among studies. This amphetamine is a substrate type
João Paulo Capela, Félix Dias Carvalho
doaj +1 more source
An improved chaos method for monitoring the depth of anaesthesia [PDF]
, 2013 This paper proposed a new method to monitor the depth of anaesthesia (DoA) by modifying the Hurst parameters in Chaos method. Two new indices (CDoA and CsDoA) are proposed to estimate the anaesthesia states of patients. In order to reduce the fluctuation
Li, Yan, Nguyen-Ky, Tai, Wen, Peng
core +1 more source
Protective effect of pentoxifylline on male Wistar rat testicular germ cell apoptosis induced by 3,4-methylenedioxymeth amphetamine [PDF]
Iranian Journal of Basic Medical Sciences, 2016 Objective(s): 3, 4-methylenedioxymethamphetamine (MDMA) one of the methamphetamine derivatives that affect the reproductive system, has not been well understood.
Mahnaz Nouri +4 more
doaj
Annals of General Psychiatry, 2020 Background PTSD is a chronic condition with high rates of comorbidity, but current treatment options are limited and not always effective. One novel approach is MDMA-assisted psychotherapy for people diagnosed with treatment-resistant PTSD, where MDMA is
Louise Morgan
doaj +1 more source
Evidence for selective executive function deficits in ecstasy/polydrug users [PDF]
, 2009 Previous research has suggested that the separate aspects of executive functioning are differentially affected by ecstasy use. Although the inhibition process appears to be unaffected by ecstasy use, it is unclear whether this is true of heavy users ...
Fisk, John, Montgomery, C.
core +1 more source
The influence of genetic and environmental factors among MDMA users in cognitive performance. [PDF]
PLoS ONE, 2011 This study is aimed to clarify the association between MDMA cumulative use and cognitive dysfunction, and the potential role of candidate genetic polymorphisms in explaining individual differences in the cognitive effects of MDMA.
Elisabet Cuyàs +12 more
doaj +1 more source
Non-Serotonergic Neurotoxicity by MDMA (Ecstasy) in Neurons Derived from Mouse P19 Embryonal Carcinoma Cells. [PDF]
PLoS ONE, 2016 3,4-methylenedioxymethamphetamine (MDMA; ecstasy) is a commonly abused recreational drug that causes neurotoxic effects in both humans and animals. The mechanism behind MDMA-induced neurotoxicity is suggested to be species-dependent and needs to be ...
Dina Popova +3 more
doaj +1 more source